Device Trial Radar · NCT06052371
Project VerioVue Enhancements - Neonate Study
Last checked: Nov 20, 2026Latest source record: Dec 27, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
99
Actual
Start
Oct 16, 2023
Primary completion
Dec 1, 2023
Study completion Dec 1, 2023
Sponsor
- Lead sponsor
- LifeScan Scotland LtdNot on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 25, 2023
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 0 days, up to 28 days
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of this performance evaluation is to compare the blood glucose results obtained using the VerioVue Blood Glucose Monitoring system (BGMS) with those obtained from a validated comparator method (iSTAT 1 Analyser) using blood obtained from neonates. The main question it aims to answer is: •How accurate is the VerioVue BGMS when compared to a product that has already been confirmed as accurate (iSTAT 1 Analyser) when hospital staff test blood taken from neonates on these instruments? Participants (neonates) will have a small amount of blood taken from a heel prick (performed by a HCP for medical purposes) or from an existing arterial line.
Conditions
- Diabetes Mellitus
Interventions
VerioVue (Enhancements) blood glucose monitoring systemDevice
VerioVue meter with expanded haematocrit range
Primary outcomes
What the sponsor says the trial is designed to measure.
- Performance evaluation: blood glucose monitoring system accuracy: BGMS vs reference instrumentTime frame: 1 hour
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Whipps Cross University Hospital (Barts Health NHS Trust)
London, United Kingdom
Queens Hospital Romford (BHRUT)
London, United Kingdom
The Royal Oldham Hospital (Northern Care Alliance NHS Foundation Trust)
Manchester, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.